Apollo Investment Outlook Revised To Positive, Ratings Affirmed At 'BBB', After Strong Management During Downturn Jun 11

  • ID: 1822067
  • June 2011
  • Standard & Poors
1 of 3


  • Apollo Investment Corp.
  • MORE

AC maintained strong capital and liquidity through the severe downturn and has resolved most of the asset quality issues in its portfolio. We are revising our outlook on AIC to positive from stable and affirming our 'BBB' counterparty credit rating on the company. We could upgrade AIC if asset quality and realized earnings remain stable as the firm resumes growth. NEW YORK (Standard & Poor's) June 13, 2011--Standard & Poor's Ratings Services said today that it revised its outlook on Apollo Investment Corp. (AIC; NASDAQ: AINV) to positive from stable. At the same time, we affirmed our ratings, including the 'BBB' counterparty credit rating, on the company. "Our outlook revision on AIC reflects the firm's improved balance sheet, and its...

Companies mentioned in this report are: Apollo Investment Corp.
Action: Affirmed
Action: Outlook: Positive

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

Apollo Investment Corp.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.